title: ACR appropriateness criteria post-treatment follow-up of renal cell carcinoma.
abstract: Although localized renal cell carcinoma can be effectively treated by surgery or ablative therapies, local or distant metastatic recurrence after treatment is not uncommon. Because recurrent disease can be effectively treated, patient surveillance after treatment of renal cell carcinoma is very important. Surveillance protocols are generally based on the primary tumor's size, stage, and nuclear grade at the time of resection, as well as patterns of tumor recurrence, including where and when metastases occur. Various imaging modalities may be used in the evaluation of these patients. Literature on the indications and usefulness of these radiologic studies is reviewed. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.
authors.affiliation: Northwestern University, Chicago, Illinois. Electronic address: DCasalino@nmff.org.
authors.forename: David D
authors.initials: DD
authors.lastname: Casalino
authors.affiliation: Cleveland Clinic, Cleveland, Ohio.
authors.forename: Erick M
authors.initials: EM
authors.lastname: Remer
authors.affiliation: Intermountain Urological Institute, Murray, Utah; American Urological Association, Linthicum, Maryland.
authors.forename: Jay T
authors.initials: JT
authors.lastname: Bishoff
authors.affiliation: Emory University Hospital, Atlanta, Georgia.
authors.forename: Courtney A
authors.initials: CA
authors.lastname: Coursey
authors.affiliation: University of Washington Medical Center, Seattle, Washington.
authors.forename: Manjiri
authors.initials: M
authors.lastname: Dighe
authors.affiliation: Scottsdale Medical Imaging, Scottsdale, Arizona.
authors.forename: Howard J
authors.initials: HJ
authors.lastname: Harvin
authors.affiliation: University of Utah, Salt Lake City, Utah.
authors.forename: Marta E
authors.initials: ME
authors.lastname: Heilbrun
authors.affiliation: Children's National Medical Center, Washington, DC; Society of Nuclear Medicine and Molecular Imaging, Reston, Virginia.
authors.forename: Massoud
authors.initials: M
authors.lastname: Majd
authors.affiliation: Northwestern University, Chicago, Illinois.
authors.forename: Paul
authors.initials: P
authors.lastname: Nikolaidis
authors.affiliation: Duke University Medical Center, Durham, North Carolina; American Urological Association, Linthicum, Maryland.
authors.forename: Glenn M
authors.initials: GM
authors.lastname: Preminger
authors.affiliation: Universty of California Los Angeles Medical Center, Los Angeles, California.
authors.forename: Steven S
authors.initials: SS
authors.lastname: Raman
authors.affiliation: Johns Hopkins Hospital, Baltimore, Maryland.
authors.forename: Sheila
authors.initials: S
authors.lastname: Sheth
authors.affiliation: University of Texas MD Anderson Cancer Center, Houston, Texas.
authors.forename: Raghunandan
authors.initials: R
authors.lastname: Vikram
authors.affiliation: Oakland University William Beaumont School of Medicine, Troy, Michigan.
authors.forename: Robert M
authors.initials: RM
authors.lastname: Weinfeld
mesh_terms: D002292:Carcinoma, Renal Cell / Q000556:secondary / Q000601:surgery*; D003952:Diagnostic Imaging; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology / Q000601:surgery*; D060787:Neoplasm Grading; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D009392:Nephrectomy
keywords: Appropriateness Criteria; ablation; follow-up; imaging; kidney cancer; renal cell carcinoma